CNL announces joint venture in production of cancer-fighting isotope
CNL and ITM announced on Oct. 23 the launch of Actinee Inc., a new joint venture company for the industrial scale production of Actinium-225.
Stay updated with breaking news from Actineer Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
CNL and ITM announced on Oct. 23 the launch of Actinee Inc., a new joint venture company for the industrial scale production of Actinium-225.
CNL and ITM announced on Oct. 23 the launch of Actinee Inc., a new joint venture company for the industrial scale production of Actinium-225.
CNL and ITM announced on Oct. 23 the launch of Actinee Inc., a new joint venture company for the industrial scale production of Actinium-225.
Germany-based radiopharmaceutical biotech company ITM Isotope Technologies Munich SE and Canadian Nuclear Laboratories have launched Actineer, a joint venture for the industrial-scale production of actinium-225.
New company will advance Actinium-225 technologies, quickly secure supply, and construct a new production facility in Canada to produce industrial-scale quantities of rare medical isotope